Sanger Sequencing

← Back to Index (🧬 Genetics)

Introduction And Definition

Core Principles And Methodology

Chain Termination Mechanism

Analysis And Visualization

Target Mutations And Diagnostic Yield

Detectable Genetic Variants

Clinical Indications In Pediatrics

Primary Diagnostic Uses

Secondary And Supportive Uses

Clinical Examples And Applications

Disease Category Specific Condition Target Gene For Sanger Sequencing
Inborn Errors Of Metabolism Phenylketonuria (PKU) PAH gene sequencing.
Monogenic Disorders Cystic fibrosis CFTR gene sequencing.
Neuromuscular Disorders Duchenne muscular dystrophy DMD gene sequencing for point mutations after deletions are ruled out.
Skeletal Dysplasias Achondroplasia Targeted testing for precise known mutations.

Advantages And Limitations

Feature Description
Key Advantages It is highly accurate for targeted genetic testing.
It remains the definitive gold standard for point mutation detection and confirmation.
Major Limitations It provides very low overall throughput.
It is highly time-consuming for large-scale genome analysis.
The method is not easily scalable for comprehensive diagnostics.
It is exceptionally expensive when analyzing multiple genes sequentially, potentially costing lakhs of rupees compared to broader sequencing methods.

Comparison With Next-Generation Sequencing

Feature Sanger Sequencing Next-Generation Sequencing (NGS)
Throughput Low throughput (analyzes one fragment at a time). High throughput (massively parallel sequencing).
Target Scope Small genes or specific mutation hotspots. Entire exome or whole genome.
Locus Heterogeneity Best for minimal locus heterogeneity. Best for extreme locus heterogeneity.
Cost-Effectiveness Expensive for large-scale or multiple gene analysis. Highly cost-effective for analyzing multiple targets simultaneously.